Adults with obesity who regained weight after bariatric surgery saw more effective weight loss with GLP-1 receptor agonist therapy compared with other weight-loss regimens. There are several medications that are approved for weight management (phentermine, topiramate-phentermine, orlistat, bupropion-naltrexone and liraglutide); however, there are limited data to support their use to treat post-bariatric weight regain. Liraglutide is a GLP-1 receptor agonist that is approved for managing type 2 diabetes mellitus and obesity. Studies have shown that postprandial levels of endogenous GLP-1 after bariatric surgery can be…

Orlistat Therapy for Obesity is a revolutionary therapy. People with obesity using orlistat for weight loss may benefit from lower rates of overall major cardiovascular events, new-onset heart failure, renal failure, and mortality. Because diet and lifestyle measures can have variable and limited effects on the initial management of obesity and bariatric surgery remains an invasive and expensive option, pharmacologic weight loss agents provide another weight-loss alternative for individuals with obesity. Orlistat, a lipase inhibitor, is 1 of 4 agents approved by the US Food and…

Maternal eating habits nutrition during pregnancy may have a long-term impact on children’s weight trajectories, researchers reported. Previous studies have largely examined the relationship between a woman’s diet during pregnancy and its impact on offspring BMI trajectories during the neonatal and early-childhood periods.Children of women who have low adherence to a Mediterranean diet have higher BMI z-scores from ages 3 to 15 years.Healthy eating during pregnancy is very important and always recommended.